About | HeinOnline Law Journal Library | HeinOnline Law Journal Library | HeinOnline

1 CBO's Estimates of the Effects of Changes in the Manufacturers' Discount in the Part D Coverage Gap 1 (July 20, 2018)

handle is hein.congrec/cboeefdd0001 and id is 1 raw text is: 




CONGRESSIONAL BUDGET OFFICE                                  Keith Hall, Director
U.S. Congress
Washington, DC  20515


                            July 20, 2018



Honorable Mark  Meadows
U.S. House of Representatives
Washington, DC   20515

Re: CBO's  Estimates of the Effects of Changes in the Manufacturers' Discount in
the Part D Coverage Gap

Dear Congressman:

In a July 2, 2018, letter, you asked about the Congressional Budget Office's cost
estimate for a provision of the Bipartisan Budget Act of 2018 (P.L. 115-123),
which was  enacted on February 9, 2018. I hope this letter answers your questions
and addresses any continuing concerns you may have about this subject.

Background
Section 53116 of the Bipartisan Budget Act requires manufacturers of brand-
name  prescription drugs to increase from 50 percent to 70 percent the discount
provided to certain Medicare Part D beneficiaries when those enrollees' spending
on brand-name  prescriptions falls within a range called the coverage gap
(sometimes referred to as the donut hole). When Part D was implemented, such
beneficiaries who were not enrolled in the low-income subsidy (LIS) program
were responsible for 100 percent of the cost of their prescriptions in that range of
spending during a given year. (The law was changed in 2010 to require
manufacturers of brand-name prescription drugs to provide a 50 percent discount
to non-LIS beneficiaries.)

CBO's  Estimate
When  the Bipartisan Budget Act was being considered, CBO estimated that
section 53116 would reduce net Medicare spending for Part D by $7.7 billion over
the 2018-2027  period.' To develop that estimate, CBO consulted extensively with


' In the table that CBO produced at that time, that effect was combined with estimated
savings for section 53113 (which modified payment rules for biosimilar drugs), resulting
in a combined estimate of $10.1 billion in federal savings over the 2018-2027 period. See
Congressional Budget Office, Estimated Direct Spending and Revenue Effects of
Division E of Senate Amendment 1930, the Bipartisan Budget Act of 2018 (February 8,
2018), www.cbo.gov/publication/53557.


www.cbo.gov

What Is HeinOnline?

HeinOnline is a subscription-based resource containing thousands of academic and legal journals from inception; complete coverage of government documents such as U.S. Statutes at Large, U.S. Code, Federal Register, Code of Federal Regulations, U.S. Reports, and much more. Documents are image-based, fully searchable PDFs with the authority of print combined with the accessibility of a user-friendly and powerful database. For more information, request a quote or trial for your organization below.



Short-term subscription options include 24 hours, 48 hours, or 1 week to HeinOnline.

Contact us for annual subscription options:

Already a HeinOnline Subscriber?

profiles profiles most